Plus, news about D&D Pharmatech and Jasper Therapeutics:
Incyte’s thrombocythemia win: The company’s antibody INCA033989, which targets and reduces cells with mutant calreticulin (mutCALR), allowed “rapid and durable” normalization of platelet counts in patients with ...
↧